228 related articles for article (PubMed ID: 31402250)
21. Prediction of nonalcoholic fatty liver in prospective liver donors.
Choudhary NS; Saraf N; Saigal S; Duseja A; Gautam D; Lipi L; Rastogi A; Goja S; Bhangui P; Ramchandra SK; Babu YR; Soin AS
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 27988988
[TBL] [Abstract][Full Text] [Related]
22. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
[TBL] [Abstract][Full Text] [Related]
23. Bioelectrical impedance analysis for evaluation of donor hepatic steatosis in living-donor liver transplantation.
Hwang S; Yu YD; Park GC; Park PJ; Choi YI; Choi NK; Kim KW; Song GW; Jung DH; Yun JS; Choi SY; Lee SG
Transplant Proc; 2010 Jun; 42(5):1492-6. PubMed ID: 20620461
[TBL] [Abstract][Full Text] [Related]
24. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
25. Body mass index evaluating donor hepatic steatosis in living donor liver transplantation.
Peng CJ; Yuan D; Li B; Wei YG; Yan LN; Wen TF; Zhao JC; Yang JY; Wang WT; Xu MQ
Transplant Proc; 2009 Nov; 41(9):3556-9. PubMed ID: 19917343
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of computed tomography for detecting hepatic steatosis in donors for liver transplantation: A meta-analysis.
Zheng D; Tian W; Zheng Z; Gu J; Guo Z; He X
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28517493
[TBL] [Abstract][Full Text] [Related]
27. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.
Cho JY; Suh KS; Kwon CH; Yi NJ; Lee KU
Surgery; 2006 Apr; 139(4):508-15. PubMed ID: 16627060
[TBL] [Abstract][Full Text] [Related]
28. Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: a single-center experience in mainland China.
Liu ZJ; Gong JP; Yan LN
Liver Transpl; 2009 Nov; 15(11):1605-12. PubMed ID: 19877230
[TBL] [Abstract][Full Text] [Related]
29. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter.
Yen YH; Kuo FY; Lin CC; Chen CL; Chang KC; Tsai MC; Hu TH
Transplant Proc; 2018 Dec; 50(10):3533-3538. PubMed ID: 30577232
[TBL] [Abstract][Full Text] [Related]
30. Impact of abdominal shape on living liver donor outcomes in mini-incision right hepatic lobectomy: Comparison among 3 techniques.
Safwan M; Nagai S; Collins K; Rizzari M; Yoshida A; Abouljoud M
Liver Transpl; 2018 Apr; 24(4):516-527. PubMed ID: 29281863
[TBL] [Abstract][Full Text] [Related]
31. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors.
Shin YH; Ko JS; Kim GS; Gwak MS; Sim WS; Lee AR; Yi HW; Joh JW
Transplant Proc; 2012 Mar; 44(2):512-5. PubMed ID: 22410058
[TBL] [Abstract][Full Text] [Related]
32. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
33. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
[TBL] [Abstract][Full Text] [Related]
34. Quantification of liver fat content with ultrasonographic attenuation measurement function: Correlation with unenhanced multidimensional computerized tomography.
Cerit M; Şendur HN; Cindil E; Erbaş G; Yalçın MM; Cerit ET; Allahverdiyeva S; Oktar SÖ; Yücel C
Clin Imaging; 2020 Sep; 65():85-93. PubMed ID: 32387801
[TBL] [Abstract][Full Text] [Related]
35. Right lobe living donors ages 55 years old and older in liver transplantation.
Kim SH; Lee EC; Shim JR; Park SJ
Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
[TBL] [Abstract][Full Text] [Related]
36. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation.
Hwang S; Lee SG; Jang SJ; Cho SH; Kim KH; Ahn CS; Moon DB; Ha TY
Liver Transpl; 2004 Jun; 10(6):721-5. PubMed ID: 15162464
[TBL] [Abstract][Full Text] [Related]
37. The Assessment of Hepatosteatosis in Living-Donor Liver Transplant: Comparison of Liver Attenuation Index and Histopathologic Results.
Sagir Kahraman A; Karakas HM; Kirimlioglu H; Kahraman B; Yilmaz S; Kirimlioglu V
Exp Clin Transplant; 2017 Feb; 15(1):69-77. PubMed ID: 26221870
[TBL] [Abstract][Full Text] [Related]
38. Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy.
Nagai S; Fujimoto Y; Kamei H; Nakamura T; Kiuchi T
Br J Surg; 2009 Apr; 96(4):437-44. PubMed ID: 19283738
[TBL] [Abstract][Full Text] [Related]
39. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
Ryan CK; Johnson LA; Germin BI; Marcos A
Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
[TBL] [Abstract][Full Text] [Related]
40. Influence of outflow-obstructed liver volume and venous communication development: A three-dimensional volume study in living donors.
Kawaguchi Y; Hasegawa K; Okura N; Maki H; Akamatsu N; Kaneko J; Arita J; Sakamoto Y; Ohtomo K; Kokudo N
Liver Transpl; 2017 Dec; 23(12):1531-1540. PubMed ID: 28834163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
